MF
JAZZ icon

Magnetar Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Magnetar Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,476
Closed -$419K – 568
2024
Q1 		$419K Sell
3,476
-16,655
-83% -$2.04M 0.01% 311
2023
Q4 		$2.48M Buy
+20,131
New +$2.51M 0.06% 187
2023
Q3 		– Sell
-24,929
Closed -$3.09M – 514
2023
Q2 		$3.09M Buy
+24,929
New +$3.35M 0.07% 163
2021
Q4 		– Sell
-86,259
Closed -$11.2M – 1457
2021
Q3 		$11.2M Buy
86,259
+30,389
+54% +$4.59M 0.11% 190
2021
Q2 		$9.93K Buy
55,870
+47,203
+545% +$8.18M 0.09% 209
2021
Q1 		$1.43M Buy
+8,667
New +$1.43M 0.01% 630
2018
Q1 		– Sell
-8,599
Closed -$1.16M – 684
2017
Q4 		$1.16M Buy
8,599
+3,046
+55% +$422K 0.02% 195
2017
Q3 		$812K Buy
5,553
+1,206
+28% +$182K 0.01% 325
2017
Q2 		$676K Buy
+4,347
New +$665K 0.01% 447
2016
Q4 		– Sell
-5,105
Closed -$620K – 205
2016
Q3 		$620K Buy
5,105
+2,997
+142% +$404K 0.01% 327
2016
Q2 		$298K Buy
+2,108
New +$311K ﹤0.01% 292
2015
Q4 		– Sell
-1,784
Closed -$237K – 420
2015
Q3 		$237K Buy
+1,784
New +$307K ﹤0.01% 374

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.22B AUM 26.01% 1-Year Est. Return

Magnetar Financial's JAZZ Position: Q2 2024 in Review

Magnetar Financial sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2024, closing a stake of 3,476 shares — an estimated $419K sold.

Magnetar Financial first reported a position in JAZZ in Q3 2015 and held it in 12 quarters. The position peaked at $11.2M in Q3 2021. 455 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

  • Magnetar Financial reported no remaining Jazz Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Magnetar Financial sold 3,476 Jazz Pharmaceuticals shares in Q2 2024, an estimated $419K.
  • Magnetar Financial first reported a position in Jazz Pharmaceuticals in Q3 2015 and held it in 12 quarters.
  • Magnetar Financial's Jazz Pharmaceuticals position peaked at $11.2M in Q3 2021.
  • 455 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on Magnetar Financial's 13F filing for Q2 2024, filed 14 Aug 2024.